Do polymorphisms inMDR1andCYP3A5genes influence the risk of cytogenetic relapse in patients with chronic myeloid leukemia on imatinib therapy?-Reference-Cited by-同舟云学术

Do polymorphisms inMDR1andCYP3A5genes influence the risk of cytogenetic relapse in patients with chronic myeloid leukemia on imatinib therapy?

Published:2017-04-03 Issue:9 Volume:58 Page:2218-2226
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Harivenkatesh Natarajan¹,Kumar Lalit²,Bakhshi Sameer²,Sharma Atul²,Kabra Madhulika³,Velpandian Thirumurthy¹,Gogia Ajay²,Shastri Shivaram S.³,Gupta Yogendra Kumar¹

Affiliation:

1. Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India;

2. Medical Oncology, All India Institute of Medical Sciences, New Delhi, India;

3. Pediatrics (Genetics Unit), All India Institute of Medical Sciences, New Delhi, India

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1287359

Reference39 articles.

1. Chronic myeloid leukemia: reminiscences and dreams

2. Chronic Myeloid Leukemia: A Historical Perspective

3. Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

4. Current Status of Imatinib as Frontline Therapy for Chronic Myeloid Leukemia

5. The pharmacogenetics of imanitib

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymorphisms in Drug Transporter and Metabolism Genes Associated with Resistance to Imatinib in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis;Scientia Pharmaceutica;2023-12-25

2. Pharmacogenomics to Predict Tumor Therapy Response: A Focus on ATP-Binding Cassette Transporters and Cytochromes P450;Journal of Personalized Medicine;2020-08-28

3. Imatinib trough levels: a potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia;Leukemia & Lymphoma;2018-08-20

4. Status of Pharmacogenomics Research in India during the last Five Years;Proceedings of the Indian National Science Academy;2017-11-01